Cardiac Rhythm Management Devices Market

Published July 2022 | 9 Pages | 5 Exhibits | Forecasts Through 2026

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This report from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore  the natural rhythm and function of the heart that can be impaired due to heart failure and cardiac arrhythmias.  

This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Abbott

AtaCor Medical

Biotronik

Boston Scientific

Cairdac

EBR Systems

Kobara Medical

Medtronic

Microport Scientific

Osypka Medical

Shree Pacetronix

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.